홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Uranium, bis(formato-kappaO)dioxo-, (T-4)-

HCID 86897
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
16984-59-1
표준 SMILES
O=CO.O=CO.[O]=[U]=[O]
InChIKey
SFIHWLKHBCDNCE-UHFFFAOYSA-N
분자식
C2H4O6U
평균 분자량
362.08 g/mol
단동위원소 질량
362.05157

개요

Uranyl formate is a chemical compound of uranium. Uranium is a chemical element that has the symbol U and atomic number 92. It is a normal part of rocks, soil, air, and water, and occurs in nature in the form of minerals. (L248, L249)

이름 및 식별자

우선 이름
Uranium, bis(formato-kappaO)dioxo-, (T-4)-
IUPAC
dioxouranium;formic acid

이름 및 동의어

dioxouranium;formic acidUranium, bis(formato-kappaO)dioxo-, (T-4)-EINECS 241-063-6

데이터베이스 식별자

CAS
16984-59-1
PubChem CID
86897

물성

구조 계산 물성

극성 표면적
109 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
6
회전 가능 결합 수
0
무거운 원자 수
9
형식 전하
0
복잡도
71.5

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 및 보호

Minimum Risk Level · 1건

Intermediate Inhalation: 0.0004 mg/m3 (Soluble uranium salts) (L134) Chronic Inhalation: 0.0003 mg/m3 (Soluble uranium salts) (L134) Intermediate Oral: 0.002 mg/kg/day (Soluble uranium salts) (L134) Intermediate Inhalation: 0.008 mg/m3 (Insoluble uranium compounds) (L134)

독성 정보

Health Effects · 1건

Uranium primarily damages the kidney, but may also damage the lungs, central nervous system, and immune system. Uranium's radioactivity is believed to damage the DNA, resulting in carcinogenic effects and reproductive and developmental damage. (L248, L249)

Exposure RoutesOral (L249) ; inhalation (L249) ; dermal (L249)
Toxicity Summary · 1건

Uranium is combined with either bicarbonate or a plasma protein in the blood but once in the kidney, it is released and forms complexes with phosphate ligands and proteins in the tubular wall, causing damage. Uranium may also inhibit both sodium transport-dependent and independent ATP utilization and mitochondrial oxidative phosphorylation in the renal proximal tubule. Uranium causes respiratory diseases by damaging alveolar epithelium type II cells in the lungs. Uranium induces c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) activation, which in turn induces tumor necrosis factor alpha (TNF-alpha) secretion and generates and inflammatory response in the lungs. Studies have shown that the more soluble the uranium salt, the more toxic it is. Ionizing radiation produced by uranium damages the DNA, resulting in gene mutations and chromosomal aberrations. This can both both initiate and promote carcinogenesis, and interfere with reproduction and development. (L249, A160)

Signs and SymptomsIngestion of uranium may cause vomiting and diarrhea. (L248)
Carcinogen Classification

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

Uranium is absorbed in low amounts via oral, inhalation, and dermal routes. Uranium in body fluids generally exists as the uranyl ion (UO2)2+ complexed with anions, such as citrate and bicarbonate, or plasma proteins. Uranium preferentially distributes to bone, liver, and kidney. The large majority of uranium that enters the body is not absorbed and is eliminated from the body via the urine and faeces. (L248)

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Uranium: Group 1, carcinogenic to humans (L135)